Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2019. Start Trial.
Date Value
November 13, 2026 6.499B
November 12, 2026 6.456B
November 11, 2026 6.539B
November 10, 2026 6.527B
November 09, 2026 6.446B
November 06, 2026 6.481B
November 05, 2026 6.470B
November 04, 2026 6.693B
November 03, 2026 6.045B
November 02, 2026 5.961B
October 30, 2026 5.913B
October 29, 2026 6.003B
October 28, 2026 5.966B
October 27, 2026 5.949B
October 26, 2026 5.800B
October 23, 2026 5.612B
October 22, 2026 5.789B
October 21, 2026 5.811B
October 20, 2026 5.917B
October 19, 2026 5.733B
October 16, 2026 5.596B
October 15, 2026 5.742B
October 14, 2026 5.584B
October 13, 2026 5.562B
October 12, 2026 5.982B
Date Value
October 09, 2026 5.979B
October 08, 2026 5.675B
October 07, 2026 5.628B
October 06, 2026 5.538B
October 05, 2026 5.680B
October 02, 2026 5.778B
October 01, 2026 5.842B
September 30, 2026 5.944B
September 29, 2026 5.993B
September 28, 2026 6.020B
September 25, 2026 6.133B
September 24, 2026 6.111B
September 23, 2026 6.109B
September 22, 2026 6.243B
September 21, 2026 6.282B
September 18, 2026 6.271B
September 17, 2026 6.724B
September 16, 2026 6.630B
September 15, 2026 6.405B
September 14, 2026 6.590B
September 11, 2026 6.685B
September 10, 2026 6.840B
September 09, 2026 6.690B
September 08, 2026 6.770B
September 04, 2026 6.858B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Incyte Corp. 20.86B
Galectin Therapeutics, Inc. 328.95M
TG Therapeutics, Inc. 10.00B
Ardelyx, Inc. 746.69M
Kodiak Sciences, Inc. 7.208B